Denis Boulay, PhD
Affiliations: |
Google:
"Denis Boulay"Mean distance: 19.39 (cluster 6)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Boulay D, Ho-Van S, Bergis O, et al. (2013) Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia? Behavioural Pharmacology. 24: 543-51 |
| Boulay D, Depoortere R, Louis C, et al. (2011) SSR181507, a dopamine Dâ‚‚ receptor and 5-HT(â‚A) receptor ligand: evidence for mixed anxiolytic- and antidepressant-like activities. Pharmacology, Biochemistry, and Behavior. 97: 428-35 |
| Boulay D, Pichat P, Dargazanli G, et al. (2008) Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacology, Biochemistry, and Behavior. 91: 47-58 |
| Depoortère R, Dargazanli G, Estenne-Bouhtou G, et al. (2005) Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 1963-85 |
| Boulay D, Depoortère R, Louis C, et al. (2004) SSR181507, a putative atypical antipsychotic with dopamine D2 antagonist and 5-HT1A agonist activities: improvement of social interaction deficits induced by phencyclidine in rats. Neuropharmacology. 46: 1121-9 |
| Depoortere R, Boulay D, Perrault G, et al. (2003) SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1889-902 |
| Naudon L, Leroux-Nicollet I, Boulay D, et al. (2001) Decreased densities of dopamine and serotonin transporters and of vesicular monoamine transporter 2 in severely kainic acid lesioned subregions of the striatum. Journal of Neural Transmission (Vienna, Austria : 1996). 108: 431-44 |
| Boulay D, Depoortere R, Oblin A, et al. (2000) Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. European Journal of Pharmacology. 391: 63-73 |
| Boulay D, Depoortere R, Perrault G, et al. (2000) Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 39-49 |
| Boulay D, Depoortere R, Perrault G, et al. (1999) Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists. Neuropharmacology. 38: 1389-96 |